A sleep disorder diagnosis is often treated as the primary clinical milestone. The patient is assessed, treatment is prescribed, and responsibility for the day‑to‑day management of therapy effectively rests with them. Patients are expected to sustain adherence indefinitely, maintain equipment, attend appointments, report symptoms accurately, and seek help when problems arise.
This model can be difficult even in ordinary chronic care. And it becomes progressively less manageable when memory, attention, executive function, or daily functioning begin to change. What may appear as disengagement or poor adherence may instead reflect a change in the patient’s cognitive health and consequent ability to manage care independently.
Sleep disorders don't stand still, and neither does cognitive decline
Sleep disruption may contribute to cognitive decline through several pathways, including reduced glymphatic clearance and disruption of slow-wave sleep.1,2 At the same time, advancing cognitive impairment can further disturb sleep as neurodegeneration affects the brain circuits that regulate circadian rhythms and arousal.3
A recent meta-analysis found that obstructive sleep apnea (OSA) is associated with a 33% higher risk of all-cause dementia and a 45% higher risk of Alzheimer's disease specifically. Insomnia carries a 36% increased risk of all-cause dementia and a 49% increased risk of Alzheimer's disease.4
Other studies have found that up to 40% of people with dementia experience sleep disturbances including sleep-disordered breathing (SDB), excessive daytime sleepiness (EDS), restless legs syndrome (RLS), rapid eye movement (REM) behavior disorder (RBD), and insomnia.5 Moreover, when formally measured, sleep disturbance prevalence reaches up to 70% among dementia patients in care homes.6
Why continuity matters as cognition changes
As dementia progresses and cognitive health worsens, the tasks required to maintain sleep treatment often become harder to perform independently. Patients may forget why a therapy was prescribed, struggle to describe sleep-related symptoms accurately, or miss follow-up appointments that would otherwise trigger needed adjustments. At the same time, sedative or anticholinergic medications may create new risks, such as daytime impairment, confusion, and falls, making sleep care inseparable from broader medication management.
Not all patients with cognitive impairment will experience these difficulties. Consequently, cognitive impairment should not be treated as evidence that a patient cannot use positive airway pressure (PAP) or oral appliances, engage in behavioral therapies, or otherwise participate in their own care. Studies suggest that some patients with mild cognitive impairment or Alzheimer's disease can maintain treatment successfully, especially when structured support is available.7
Caregivers as the bridge
Caregivers are indispensable to continuity in sleep care. They typically notice patient struggles with therapy adherence, track overnight changes, reinforce routines, troubleshoot device problems, and report whether the patient is more confused, more restless, or harder to wake in the morning.
In many settings, these responsibilities are transferred informally. Caregivers are expected to support sleep interventions and devices without structured education on the purpose of treatment, common points of failure, escalation pathways, or when the clinical sleep care team should be re-engaged.
Dementia-supportive sleep care models should therefore explicitly include caregiver support in the pathways. Guideline bodies and care programs could specify minimum caregiver-training requirements for dementia-sleep disorder pathways, including how sleep-related changes should be documented, how declining therapy adherence should be flagged, and when reassessment should be triggered.
Device design matters too. Regulators, standards bodies, and procurement programs should incentivize device design that accounts for cognitive impairment. This can be done, for example, by incorporating usability for patients with mild cognitive impairment (MCI) or dementia, as well as their caregivers, into approval, coverage, or purchasing decisions alongside traditional performance metrics.
Sleep as a pillar of dementia-supportive chronic care
Chronic risk management in dementia care is becoming increasingly systematic, but one domain remains underrepresented. Falls prevention, cardiovascular risk management, medication reconciliation, and nutritional support are now standard components of structured dementia care programs, yet sleep is not.
Sleep disorders share several features with those established pillars. They are highly prevalent in the dementia population. They have measurable downstream consequences (including faster cognitive decline risk, higher rates of institutionalization, and greater caregiver burden) that compound other clinical risks.4,8 They interact directly with the interventions already in the care plan. Sedative-hypnotic medications may increase fall risk; untreated OSA worsens cardiovascular outcomes; and sleep disruption amplifies the behavioral and psychological symptoms that complicate every other aspect of dementia management. And just as critically, they require ongoing monitoring and adjustment rather than a single, discrete intervention.8-10
Five-point sleep care continuity model in dementi
In practice, structured sleep care in dementia could be organized around five core elements:
- A baseline sleep assessment at or near the point of cognitive impairment diagnosis.
- PAP adherence and efficacy tracked alongside other chronic condition monitoring.
- Medication review that explicitly accounts for sedative-hypnotic and polypharmacy risk.
- Caregiver-inclusive follow-up.
- Defined triggers for re-evaluation as the disease progresses.
This simply requires integration into the chronic care infrastructure already being built around these patients.
The broader care coordination direction supports this. Value-based care models increasingly recognize that dementia management cannot be fragmented across isolated specialists. In the U.S., the Centers for Medicare & Medicaid Services (CMS) Guiding an Improved Dementia Experience (GUIDE) Model positions comprehensive, coordinated dementia care as a reimbursable priority.11
In France, the Plan Maladies Neuro‑Dégénératives and the newer National Neurodegenerative Diseases Strategy 2025–2030 aim to structure care pathways and strengthen support for people living with neurodegenerative diseases and their close relatives.12,13 Similarly in Japan, the Orange and New Orange Plans focus on community‑based integrated dementia care and assistance for family caregivers.14
These signal growing policy and reimbursement support for the coordinated, caregiver-inclusive infrastructure into which ongoing sleep care should be integrated.
Monitoring, reassessment, and systems design
A systems-based approach creates room for remote monitoring and more intelligent follow-up. PAP adherence data, leak patterns, residual events, and repeated nights of non-use may help clinicians identify when support needs are changing, even if those data are not themselves validated measures of cognitive decline.
Over time, longitudinal sleep data may become more useful as an early-warning layer within dementia care, especially if analytic tools can identify patterns associated with treatment failure, functional decline, or caregiver strain. Early research applying machine learning to nocturnal activity and sleep sensor data in dementia populations has shown that analyzing changes in patterns can enable earlier detection of health deterioration, such as falls and respiratory issues, before overt clinical symptoms present themselves.
Continuity should follow changing capacity
If dementia care models are already moving toward comprehensive assessments, ongoing monitoring, care coordination, caregiver support, and efforts to delay institutionalization, sleep management should be built into that infrastructure rather than left at the margins.
A treatment plan that was appropriate at diagnosis may not be practical several years later. Patients may need clearer instructions, more frequent contact, different equipment, or greater caregiver involvement. Caregivers may also need training, respite, or a simpler route to support.
In the U.S., CMS could expand dementia-care models such as GUIDE to explicitly recognize sleep disorder management as part of coordinated dementia care, including reassessment of treatment burden, caregiver training, and referral pathways back to sleep specialists when support needs change. In the U.K., the National Institute for Health and Care Excellence (NICE) dementia management guidance could expand its provisions on sleep management by strengthening its management directives and adding periodic sleep disorder reassessment and caregiver support into its recommendations.
The answer is not necessarily more intensive care at every stage, but care designed to recognize when capacity, responsibility, or treatment burden has changed and respond accordingly.
